Psychotherapy and paroxetine: cost effective for severe IBS, or a waste of resources.
Chitkara
Denesh K
DK
Cremonini
Filippo
F
Talley
Nicholas J
NJ
D018687:Antidepressive Agents, Second-Generation / Q000191:economics / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D017048:Health Care Costs; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000628:therapy*; D017374:Paroxetine / Q000191:economics / Q000627:therapeutic use*; D011613:Psychotherapy / Q000191:economics
D018687:Antidepressive Agents, Second-Generation; D017374:Paroxetine